MedPath

A Randomized Trial Comparing Horizontal and Vertical Vaginal Cuff Closure

Not Applicable
Completed
Conditions
Hysterectomy
Interventions
Procedure: Cuff Closure
Registration Number
NCT02117492
Lead Sponsor
Milton S. Hershey Medical Center
Brief Summary

The purpose of this study is to evaluate the possible impacts of two techniques of vaginal cuff closure during robotic hysterectomy. We aim to compare vertical vs horizontal vaginal cuff closure and the impact that these techniques have on vaginal length, sexual function, and overall complication rates.

Detailed Description

A Validated questionnaire the Female Sexual Function Index (FSFI) and total vaginal lengths will be used to evaluate patients pre-operatively, at 4-6 weeks post-operatively, and 6 months post operatively. The FSFI will also be sent to the patient 12 months post operatively. These data will be used to assess sexual function and total vaginal length in patients undergoing minimally invasive hysterectomy. The study endpoint will occur after the 12 month follow-up questionnaire. Additionally, all complications following surgery will be tracked over the study period for comparison.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
70
Inclusion Criteria
  1. Female premenopausal patients undergoing robot assisted total laparoscopic hysterectomy
Exclusion Criteria
  1. Adults unable to consent
  2. Children under the age of 18
  3. Pregnant women
  4. Prisoners
  5. Post-menopausal women
  6. Women with the known preoperative need for bowel or genitourinary surgery at the time of hysterectomy
  7. Patients unable to consent to the procedure in the English language

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vertical CuffCuff ClosureVaginal cuff closure will be done vertically.
Horizontal CuffCuff ClosureVaginal cuff closure will be done horizontally.
Primary Outcome Measures
NameTimeMethod
Vaginal Lengthup to 4-6 weeks post-operative

The primary endpoint measured in the study will be total vaginal length. This will be measured preoperatively, at 4-6 weeks postoperatively.

Secondary Outcome Measures
NameTimeMethod
Sexual FunctionPre-operative, 6 and 12 months post-operativey

Secondary outcomes will include sexual function measured with FSFI preoperatively and at 6 months and 12 months post operatively.

Trial Locations

Locations (1)

Penn State Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath